Medication Treatments for Alzheimer's Disease

Green Clock Hours: 1.00

Alzheimer’s disease (AD) is a progressive, neurodegenerative disease that currently affects 5.8 million people in the U.S. and is projected to affect 13.8 million people by the year 2050 (Alzheimer’s Association, 2019). The treatment approach to managing patients with dementia caused by AD is through symptom control. The pathophysiology is not entirely known, and there is no drug available to prevent or cure the disorder. All FDA-approved drugs work by modulating neurotransmitters, either acetylcholine or glutamate. Antidepressants, neuroleptics, anxiolytics, and anticonvulsants are also used to influence mood and behavior. As more research is completed and data collected, possible links to genetics, nutrition, and chemical entities may provide insight into future modes of therapy.

Read More

$32.00

Course Description

Alzheimer’s disease (AD) is a progressive, neurodegenerative disease that currently affects 5.8 million people in the U.S. and is projected to affect 13.8 million people by the year 2050 (Alzheimer’s Association, 2019). The treatment approach to managing patients with dementia caused by AD is through symptom control. The pathophysiology is not entirely known, and there is no drug available to prevent or cure the disorder. All FDA-approved drugs work by modulating neurotransmitters, either acetylcholine or glutamate. Antidepressants, neuroleptics, anxiolytics, and anticonvulsants are also used to influence mood and behavior. As more research is completed and data collected, possible links to genetics, nutrition, and chemical entities may provide insight into future modes of therapy.

Only $249
Want Unlimited Access?
The Academy All Access Subscription provides 1-click enrollment into 1,450+ courses for one low price.
Only $249